Prevalence and determinants of anxiety, depression and comorbid anxiety-depression symptoms among adolescents in Ebola-affected zones.

Journal: BJPsych open

Volume: 9

Issue: 6

Year of Publication: 

Affiliated Institutions:  School of Psychology, University of Ottawa, Ottawa, Ontario, Canada; Interdisciplinary Centre for Black Health, University of Ottawa, Ottawa, Ontario, Canada; University of Ottawa Research Chair on Black Health, Ottawa, Ontario, Canada. School of Psychology, University of Ottawa, Ottawa, Ontario, Canada. Department of Clinical Psychology and Health, Monterrey Institute of Technology and Higher Education, Monterrey, Mexico. Department of Psychology, Carleton University, Ottawa, Ontario, Canada. Interdisciplinary School of Population Health, University of Ottawa, Ottawa, Ontario, Canada. Department of Psychology, University of Kinshasa, Kinshasa, DR, Congo. Department of Psychology, Université Bourgogne Franche Comté, Bourgogne, France. Division of Social and Transcultural Psychiatry, McGill University, Montreal, Canada.

Abstract summary 

Ebola virus disease (EVD) has been shown to be associated with poor mental health in affected zones. However, no study has yet explored its impact on adolescents' mental health.This study aimed to assess the prevalence and risk factors associated with depression and anxiety symptoms among adolescents in EVD-affected areas in the Equateur Province of the Democratic Republic of the Congo during the COVID-19 pandemic.A provincial sample of adolescents aged 12-17 years ( = 14.84, s.d. = 1.49) living in the 18 urban and rural areas affected by the 2018 EVD outbreak completed a two-wave longitudinal survey. Surveys assessed symptoms of depression and anxiety, exposure to Ebola, social support and sociodemographic information.A total of 490 participants completed the baseline and follow-up surveys, 50% of whom were female. Elevated and worsened depressive symptoms were observed among participants from the baseline (56.94%) to the follow-up (91.43%; = -11.37, < 0.001), whereas anxiety symptoms decreased from the baseline (36.33%) to follow-up (24.90%; = 4.06, < 0.001). The final generalised estimating equation model showed that anxiety symptoms decreased over time ( = -3.92, < 0.001), while depression symptoms increased ( = 4.79, < 0.001). Stigmatisation related to Ebola positively predicted anxiety ( = 5.41, < 0.001) and depression symptoms ( = 0.4452, = 0.009). Social support negatively predicted anxiety ( = -1.13, = 0.004) and depression ( = -0.98, < 0.001) symptoms but only moderated the association between stigmatisation and depression symptoms ( = -0.67, < 0.001).Most adolescents living in EVD-affected areas experience mental health issues. Stigmatisation related to EVD and living in urban areas are the most consistent predictors of mental health problems. Nevertheless, social support remains a protective factor for depression and anxiety symptoms and a necessary resource for building resilience.

Authors & Co-authors:  Cénat Jude Mary JM Dromer Elisabeth E Mistry Shruti S Villarreal Daniela Gonzalez DG Moshirian Farahi Seyed Mohammad Mahdi SMM Dalexis Rose Darly RD Darius Wina Paul WP Bukaka Jacqueline J Balayulu-Makila Oléa O Luyeye Noble N Derivois Daniel D Rousseau Cécile C

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Adepoju P. Ebola and COVID-19 in DR Congo and Guinea. Lancet Infect Dis 2021; 21: 461.
Authors :  12
Identifiers
Doi : e196
SSN : 2056-4724
Study Population
Male,Female
Mesh Terms
Other Terms
COVID-19;Ebola virus disease;anxiety;depression;stigmatisation
Study Design
Study Approach
Country of Study
Republic of the congo
Publication Country
England